# SOLA Pharmaceuticals LLC, Baton Rouge, LA – FDA Inspections

Source: https://www.keypedia.com/companies/sola-pharmaceuticals-llc/d3c93547-0516-49be-b228-d37582081dbb

> Inspection records and compliance data for SOLA Pharmaceuticals LLC in Baton Rouge, Louisiana. 3 FDA inspections on record, 1 Form 483, last inspected January 08, 2025.

---

## Details

- Name: SOLA Pharmaceuticals LLC
- FEI Number: 3014030941
- Address Line 1: 655 Highlandia Dr Ste B
- City: Baton Rouge
- State: Louisiana
- Zip Code: 70810
- Country Name: United States
- Address: 655 Highlandia Dr Ste B, Baton Rouge, Louisiana 70810, United States
- Country: United States

## Related Documents

- FDA Inspection 1258442 - SOLA Pharmaceuticals LLC - 2025-01-08 — source: FDA, date: January 8, 2025
- FDA Inspection 1258442 - SOLA Pharmaceuticals LLC - 2025-01-08 — classification: No Action Indicated (NAI), source: FDA, date: January 8, 2025
- [483 - SOLA Pharmaceuticals LLC - 2024-12-18](https://www.keypedia.com/records/483/sola-pharmaceuticals-llc/acd81ebc-d48e-4503-80b3-bdd3d3018ef4) — source: FDA, date: December 18, 2024
- [FDA Inspection 1256965 - SOLA Pharmaceuticals LLC - 2024-12-18](https://www.keypedia.com/records/fda_inspections/sola-pharmaceuticals-llc/c213fd93-f106-499a-806f-ef3b23614b3d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 18, 2024
- [FDA Inspection 1088275 - SOLA Pharmaceuticals LLC - 2019-03-22](https://www.keypedia.com/records/fda_inspections/sola-pharmaceuticals-llc/6de6f651-d0cb-4816-9be3-c15168a5fb24) — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2019

## Related Companies

- [Travere Therapeutics, Inc.](https://www.keypedia.com/companies/travere-therapeutics-inc/a6c4209e-7c15-4a5f-9ff2-8ab137141d41)
- [Larken Laboratories, Inc.](https://www.keypedia.com/companies/larken-laboratories-inc/538ebd18-afce-4280-b081-417c09f92d4f)
- [Misemer Pharmaceutical](https://www.keypedia.com/companies/misemer-pharmaceutical/8519598e-b9c3-4cfa-a622-37863a4f50fe)
- [Amring Pharmaceuticals Inc](https://www.keypedia.com/companies/amring-pharmaceuticals-inc/fe0b95bd-9f8d-47ef-b219-b2b2eca1aa26)
- [Lundbeck  LLC](https://www.keypedia.com/companies/lundbeck-llc/3bc370e3-3e53-4898-9d27-a907cd6b4494)
- [Geron Corporation](https://www.keypedia.com/companies/geron-corporation/f3dace20-4cd8-4193-86bc-9f62d11576de)
- [Zyla Life Sciences US Inc.](https://www.keypedia.com/companies/zyla-life-sciences-us-inc/9afafefd-863b-415c-9b10-3c39950b573b)
- [Rare Disease Therapeutics, Inc.](https://www.keypedia.com/companies/rare-disease-therapeutics-inc/13e04bbf-1be0-4636-b713-6ba8817b5157)
- [EDW PHARMA, INC](https://www.keypedia.com/companies/edw-pharma-inc/69c91922-fc45-4b91-be52-5c8fdd504119)
- [Catalyst Pharmaceuticals, Inc.](https://www.keypedia.com/companies/catalyst-pharmaceuticals-inc/b49a7d5c-19ad-4b34-acbc-3fc628d1825a)

## Related Officers

- [Director of Compliance Branch](https://www.keypedia.com/people/ronda-r-lloyd-jones/1446ba41-f1f2-4d40-8902-021b2bef3a53)
- [Milton J. De Jesus Tavarez](https://www.keypedia.com/people/milton-j-de-jesus-tavarez/24d4ed81-7c7e-42d2-8888-1c56c25eec67)